Strategic Partnerships Dana-Farber is actively expanding collaborations with academic and health system partners (e.g., Merrimack Health, Trinity Health Of New England) and engaging in DON processes to reestablish services, indicating opportunities to offer scalable oncology care solutions, care coordination platforms, and regulatory-compliant project management support.

Clinical Trial Enablement With ongoing involvement in open-source trial matching via its Knowledge Systems Group and recognition at ASH, Dana-Farber seeks advanced trial enrollment, data integration, and patient matching technologies, presenting upsell potential for AI-driven eligibility, EHR interoperability, and clinical trial workflow optimization.

R&D & Innovation Awards for leadership in basic science and drug discovery leadership suggest opportunities to partner on research infrastructure, lab informatics, data analytics, and grant-supported technology platforms that enhance translational research and collaboration with pharma partners.

Financial Leverage Significant revenue scale paired with targeted funding from philanthropic sources signals a readiness to consider cost-effective enterprise solutions, managed services, and subscription-based platforms for oncology data management, patient engagement, and remote care operations.

Digital & IT Footprint A diverse tech stack including collaboration, media, and IoT-like LonWorks indicates openness to modern digital transformation services, cloud-based collaboration, data security, and patient-centric communication tools to streamline care delivery and stakeholder engagement.